logo
As women face childbirth far from home, B.C. maternity doctors sound alarm

As women face childbirth far from home, B.C. maternity doctors sound alarm

Yahoo02-08-2025
Thirty-six weeks pregnant, and away from her kids and community in a hotel in Prince George, Brittany King is trying to stay calm.
The expectant mother is 600 kilometres from her home in Kitimat because the local hospital cannot support the twin babies she will deliver by C-section later this month. Prince George is better than Vancouver — a possibility that was raised earlier in her pregnancy — but it's still far from her support network at one of the most vulnerable times in her life.
'I'm just trying to take it day by day,' said King. 'I'm doing a lot of deep breathing.'
In a statement released Friday, the obstetrics and gynecologists section of Doctors of B.C. sounded the alarm about the shortage of maternity specialists in B.C. and the impacts on women and babies whose lives 'depend on a doctor's middle-of-the-night decision-making.'
Prince George and Kamloops, where patients were told they may need to be transferred to other hospitals to give birth, are the first B.C. sites to reach critical staffing levels, said the statement. 'There are many other communities around the province whose specialists are also reaching their limits.'
Also Friday, Northern Health announced it had found specialist coverage for the Prince George hospital for August and September, eliminating the need to transfer high-risk patients. And while the situation in Kamloops remains the same, with patients not attached to a local maternity care provider potentially being transferred to other hospitals in the region, doctors have been able to cover the gaps, said a statement from Dr. Peter Bosma, executive medical director for Interior Health.
'We ask everyone to present to (Royal Inland Hospital) when needing urgent care, where they will be assessed and the best care plan can be put into place,' he said. 'When possible, a family practitioner with enhanced obstetrical surgical skills will also be available to support deliveries as appropriate within their scope. That was the case over last weekend, and all patients presented were able to deliver their babies locally in Kamloops.'
While acute maternity care is most affected by specialist shortages, B.C. women of every age are experiencing limited access and long waitlists to see a specialist, said the statement from the obstetrics and gynecologists section.
'The closures that are making the news are due to the doctors remaining in these communities having to juggle all the competing women's health priorities they are responsible for.'
The statement attributed the shortage to 'years of physicians doing everything they can to maintain services and burning themselves out,' as well as 'impossible working environments' that have led to departures.
The statement said the obstetrics and gynecologists section has been working with the B.C. government for the past year-and-a-half, but the province's plan to recruit more doctors from the U.S. cannot be the only solution.
Dr. Douglas Waterman, a New Westminster gynecologist, said the Ministry of Health needs to look closely at how the shortage developed.
'Providing obstetrical care has become more demanding over the past 20 to 30 years,' Waterman said in a written interview. 'Women are having their children later in their lives. They are also having fewer babies. Therefore, more pregnancies are first-time births, and are more likely to have medical complications. These pregnancies are more likely to need involvement by the obstetrician.'
Waterman said during talks with government there was acknowledgment the current method of reimbursement was not working.
'We were starting to work toward an alternate payment plan,' he said. 'Hopefully, this work will continue and reach an appropriate outcome. In the meantime, recruiting new physicians to a system that is not working will not be a long-term solution. They will be subject to the same problems of burnout, job dissatisfaction and leaving.'
Waterman said Canada has one of the best records for perinatal outcome in the world.
'That did not happen by chance. We need a well-organized and sustainable system for delivering obstetrical care all around the province. Our mothers and their babies deserve nothing less.'
In a statement, the B.C. Ministry of Health said hospitals and the health authorities 'take every step possible to fill gaps in health-care provider coverage to make sure people get the care they need, when they need it.' Health authorities also support families with contingency planning if they need to relocate for a birth.
The statement emphasized the work the ministry is doing to recruit doctors from the U.S. and other countries by streamlining credential recognition.
'Many health professionals have expressed interest in making the move to B.C.,' it said.
Nicole Penner, expecting her fourth baby in a few weeks, is scrambling to figure out where to go to deliver her baby. Last time, she gave birth a few minutes after entering the doors of the Prince George hospital. At her last appointment, her midwife told her she would need to go to Quesnel or Vanderhoof, more than an hour's drive away.
On Friday, after Northern Health announced it had found specialist coverage for August and September, Penner was even more confused about where to go.
'I'm scared,' she said. 'Do I call the hospital, or do I start driving to Vanderhoof? When you're in labour, you can't think. It's the only thing on your mind. I can't figure out where to go and who will take care of my kids. What if my labour is short? What if I don't make it to the hospital on time?'
For Brittany King, facing childbirth far from home regardless of the situation in Prince George, there are no easy answers. The family has started a GoFundMe to help with expenses.
'It sucks. What else can I say?'
gluymes@postmedia.com
Related
'Something fundamentally wrong': More disruptions hit maternity care in Kamloops, Prince George
Conservative bill on prenatal and postnatal care in B.C. a rare opportunity for bipartisan co-operation
Surrey nurse on maternity leave donates breast milk to help tiniest patients
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Lessons for Parkinson's From MS, and Vice Versa
Lessons for Parkinson's From MS, and Vice Versa

Medscape

time35 minutes ago

  • Medscape

Lessons for Parkinson's From MS, and Vice Versa

This transcript has been edited for clarity. Indu Subramanian, MD: Hi, everyone. Welcome to Medscape. I'm so excited to have my friend and colleague, Prof Lorraine Kalia, join us today to talk about a very cool topic: what we can learn from multiple sclerosis (MS) studies and therapies, and how we can maybe translate that to some of the problems that we've been having in the Parkinson's world. Prof Lorraine Kalia is a clinical scientist at the Krembil Institute. She's also an amazing neurologist at the University of Toronto, which is my alma mater. Welcome, Lorraine. Lorraine V. Kalia, MD, PhD: Hi, Indu. Thanks for having me. Meeting of MS and PD Minds Subramanian: My name is Dr Indu Subramanian. I'm based at UCLA. Maybe we can get right into this. You had this very cool meeting in November 2022, and you had experts in the MS world as well as the Parkinson's disease world. Tell us a little bit about what inspired that meeting in the first place. Kalia: It's a bit of a personal story, actually. I might date myself a little bit, but I was a medical student during the time of the natalizumab development. At that time, I thought I was going to be an MS neurologist. Even back then, they already had a couple of disease-modifying therapies for MS and I thought, You know what, I think MS is good. I think they're in good shape. As a scientist with an understanding of the biology behind disease, it was clear to me that there still was a large amount of work needing to be done in Parkinson's disease because that's obviously how we translate things into having disease-modifying therapies. That was part of the reason — not the only reason — why I shifted into the movement disorder space. Fast-forward many years later: I often give talks around the lack of disease-modifying therapies for Parkinson's disease by introducing MS. Sometimes when you ask why we don't have a disease-modifying therapy for Parkinson's, people throw up their hands and say, "Well, you know, neurologic diseases are complicated." I'll often use the MS example to demonstrate that actually there is much that can be done in the neurologic space and there's been a lot of successes in MS. I was once giving this talk, and as a consequence of this talk, had a conversation with Parkinson Canada who thought, wow, that's an interesting idea around MS being so successful and PD lagging behind. We came up with the idea of having a meeting in Toronto. We obviously have very strong Parkinson's researchers in Toronto, but also a very strong MS team at the Saint Michael's Hospital. I collaborated with a colleague — actually, we were residents together — to bring world experts to Toronto to sit around a table, which is what we did, and talk about where we are in MS and where we are in Parkinson's disease. We were looking for common ground but also looking to see what is different and how we might think about things differently that might have led to the different paths that we've experienced in our fields. Lessons From MS Subramanian: What do you think some take-home messages for the clinician would be from that discussion? I think it was a very cool paper. Kalia: Maybe the take-home messages is it's complicated, which is not as simple as I had hoped. I hoped that we'd come back with clear messages of what we really need to do with Parkinson's. I think we found common ground for one thing. I think it's fair to say that MS has done remarkably well at treating inflammation. All of their drugs are based on that, and they will recognize that they have challenges in terms of treating the neurodegenerative part of their condition. Now that we increasingly recognize that inflammation is a part of Parkinson's disease and there's increased work around the immune basis to the disease, I think we are going to be able to take advantage of what MS has done and learn to hopefully make advances that way. For anybody who's learned about MS , its successes have hanged heavily on its neuroimaging biomarkers of MRI. Of course, biomarkers are needed for the development of Parkinson's disease , and perhaps more work into the neuroimaging piece as well as the biospecimen biomarkers is key to starting to be able to have different kinds of outcome measures. Not the clinical outcome measures that we're using right now in basically all of our clinical trials, but to have early biomarker outcome measures that will help to inform us for our later clinical trials. The other commonality between the two is this concept of earlier disease. We have our prodromal Parkinson's disease and MS has their radiologically isolated syndrome. Up until now, logically, it has made sense to us that we should treat earlier in Parkinson's disease, and that will likely give us better successes. In the MS space, there's actually proof of that. They have clinical trials showing the benefit of treating people in the radiologically isolated syndrome state. While in Parkinson's disease, it has been theoretical and seems to make sense to all of us, we don't have any hard proof to say that treating earlier is better, whereas in MS they have already demonstrated that. I think this then provides us with actual proof in the pudding that that approach really does have implications for disease progression. PD Ahead of MS for Lifestyle Subramanian: Absolutely. I think both diseases in many ways have revolutionized since back in the day when we were in training. The MS models have really come a long way, with many patients doing very well for a long time. I think we have to really take a look at where our feelings are and how we can do better. I'm excited just about the concept of identifying people early and then getting people who may be even at risk for developing Parkinson's into lifestyle measures and wellness choices. I think MS has done a great job of that as well. Can you speak a little bit about that from your own perspective? Kalia: I don't think it came out in the paper, but it came out in our discussions that as a field and as a patient population, there's probably been more embrace of lifestyle measures and physical activity in Parkinson's, which I think is kudos to us in Parkinson's disease. Maybe it's in part because in MS they have these drugs that came through one after another after another, and there's this heavy pharma management of MS that they haven't had to explore the lifestyle assets. There's a large amount that MS has to learn from Parkinson's disease, in terms of putting in place so many of the things that we discuss in Parkinson's, whether it be diet, sleep, stress or mindfulness — all of these things. I think that in Parkinson's, we're further ahead. Subramanian: Absolutely. I agree with you. I'm excited to learn from these other disease states that we train under in residency. We see these patients and we can open our minds to looking at different lenses, for sure. Thank you so much for spending the time and chatting about this. Kudos to you for having that meeting. It sounds like a great opportunity to bring great minds together. Kalia: Yes. Hopefully, we can do more of this in the future. Subramanian: Go Canada. Thank you for joining us, everyone.

Sugar cookies sold in 20 states recalled for potential wood contamination: See map
Sugar cookies sold in 20 states recalled for potential wood contamination: See map

Yahoo

time4 hours ago

  • Yahoo

Sugar cookies sold in 20 states recalled for potential wood contamination: See map

Sugar cookies sold in 20 states recalled for potential wood contamination: See map Hundreds of cases of sugar cookies sold at Target are being recalled for potential contamination by a "foreign material," according to a notice posted to the Food and Drug Administration's website. The voluntary recall for the Favorite Day Bakery Frosted Sugar Cookies was issued on July 22 by Give and Go Prepared Foods Corp. in Canada, according to the FDA. Favorite Day is a private label brand sold at Target. In total, 803 cases are being recalled due to the potential foreign contamination. The cookies, which could potentially contain wood, were distributed across 20 different states and Washington, D.C., the notice stated. The recall is classified as a Class II recall, meaning the product "may cause temporary or medically reversible adverse health consequences," according to the FDA. A press release was not issued for the recall, but as of Sunday, Aug. 10, the recall is ongoing. Target did not immediately respond to a request for comment from USA TODAY on Aug. 10. Where were the recalled sugar cookies sold? The cookies were sold in the following states and districts: Connecticut District of Columbia Delaware Illinois Indiana Kentucky Massachusetts Maryland Maine Michigan Montana North Carolina New Hampshire New Jersey New York Ohio Pennsylvania Rhode Island Tennessee Virginia Vermont How to tell if you purchased the recalled product The recalled cookies, Favorite Day Bakery Frosted Sugar Cookies, 10 count, were distributed by Target and produced in Canada. The cookies are a part of Lot 25195, with the UPC number 85239-41250 3. The packs of cookies have varying Best By Dates, as that is determined by when the retailer removed the cookies from the freezers, according to the notice. Julia is a trending reporter for USA TODAY. Connect with her on LinkedIn, X, Instagram and TikTok: @juliamariegz, or email her at jgomez@ This article originally appeared on USA TODAY: Favorite Day sugar cookies sold at Target in 20 states recalled Solve the daily Crossword

Cosmetic Surgery Market Size to Reach USD 83.34 Billion by 2034, Says Towards Healthcare Study
Cosmetic Surgery Market Size to Reach USD 83.34 Billion by 2034, Says Towards Healthcare Study

Yahoo

time5 hours ago

  • Yahoo

Cosmetic Surgery Market Size to Reach USD 83.34 Billion by 2034, Says Towards Healthcare Study

The global cosmetic surgery market is valued at USD 59.17 billion in 2025 and is projected to reach approximately USD 83.34 billion by 2034, expanding at a CAGR of 3.84% over the forecast period. Ottawa, Aug. 11, 2025 (GLOBE NEWSWIRE) -- According to a study published by Towards Healthcare, a sister firm of Precedence Research, the global cosmetic surgery market size was valued at USD 56.98 billion in 2024 and is projected to reach approximately USD 83.34 billion by 2034, growing at a CAGR of 3.84% between 2024 and 2034. The growth of the market is driven by the growing demand for aesthetic enhancements, and demand for flawless appearance fuels the growth of the market, with enhanced and improved technology driving the growth of the market. The Complete Study is Now Available for Immediate Access | Download the Sample Pages of this Report @ Key Takeaways North America dominated the global cosmetic surgery market in 2024. Europe is anticipated to grow at the highest CAGR in the market during the forecast period. By procedure, the surgical procedures segment held a dominant presence in the market in 2024. By procedures, the non-surgical procedures segment is anticipated to grow at the fastest rate in the market during the studied years. By gender, the female segment was dominant in the market in 2024. By gender, the male segment is predicted to grow at the highest CAGR in the market. By age group, the 35 to 50-year segment held the highest share of the market in 2024. By age group, the 19 to 34-year segment is estimated to grow at the fastest CAGR during the predicted timeframe. By provider, the hospitals & specialty clinics segment held the largest share of the market. By provider, the spas & cosmetic surgery centers segment is projected to grow at the fastest rate in the cosmetic surgery market during the forecast period. What is the Growth Potential Responsible for the Growth of the Cosmetic Surgery Market? Cosmetic surgery involves medical methods to improve or enhance a person's appearance, using both surgical and non-surgical techniques. Usually performed on healthy areas for aesthetic reasons rather than medical or reconstructive needs, the market is rapidly expanding. This growth is driven by increasing beauty awareness, heavily influenced by social media and celebrities, which boosts demand for cosmetic enhancements. Advances in technology have made procedures safer, less invasive, and more affordable, attracting more participants. Additionally, rising disposable incomes and better access to qualified professionals encourage more people to pursue cosmetic treatments. The pursuit of a youthful look and greater self-confidence significantly contributes to the market's continuous growth across different age groups and regions. You can place an order or ask any questions, please feel free to contact us at sales@ What are the Growing Trends Associated with the Cosmetic Surgery Market? Rising Demand for Cosmetic Procedures: The growth of the cosmetic surgery market due to rising demand increases the awareness and adoption, fueling growth. Technological Advancements: The advanced technology demanded by consumers for surgical processing and for enhancing the appeal drives the growth. Minimally Invasive Procedures: Demand and adoption of minimally invasive therapy and surgery for quick recovery and enhancement of the procedure fuel the growth. Natural-Looking Enhancements: The growing demand from consumers for enhanced and natural-looking results increases adoption, fueling the growth of the market. What is the Growing Challenge in the Cosmetic Surgery Market? The key challenge that hinders the growth of the market is the high cost and limited access, which in turn makes them inaccessible to a large population, limiting the growth of the market. The safety concerns and complications associated with the risks of infections, nerve damage, and scarring also decrease the adoption, limiting the growth. Other key challenges are the social and ethical considerations, competition, and regulatory hurdles that hinder the growth and expansion of the market. Regional Analysis How Did North America Dominate the Cosmetic Surgery Market in 2024? North America dominated the global market in 2024, due to its advanced healthcare infrastructure, cutting-edge cosmetic technologies, and experienced, board-certified surgeons. The region's rising demand for both invasive and non-invasive procedures is driven by cultural acceptance and a focus on personal aesthetics. Additionally, North America is a key destination for medical tourism, attracting patients from abroad for treatments, which boosts its market growth. In 2024, Americans underwent roughly 1.6 million surgical cosmetic procedures and 28.5 million minimally invasive treatments. Top surgeries: liposuction (~349,728), breast augmentation (~306,196), tummy tuck (~171,064), breast lift (~153,616), eyelid surgery (~120,755). Top injectables: neuromodulators (~9.88 million) and HA fillers (~5.33 million). In Canada, cosmetic surgery trends reflect increasing body positivity coupled with personal enhancement. Influences include American media, aging demographics seeking rejuvenation, and remote work enabling discrete recoveries. Accessibility via medical tourism and financing plans also play a role. Natural-looking results and non-invasive options are particularly favored among younger generations. What Caused Europe to Experience the Fastest Growth in the Cosmetic Surgery Market in the Forecast Period? Europe is anticipated to grow at the highest CAGR in the market during the forecast period. Innovations in minimally invasive procedures have improved safety and appeal. The aging population is also increasing the need for anti-aging treatments like Botox and facelifts. Furthermore, cultural acceptance of cosmetic procedures, strengthened by media and celebrity influence, encourages more individuals to seek aesthetic enhancements. Europe's strong position in medical tourism, especially in countries like Turkey and Poland, further drives its rapid market expansion. The cosmetic surgery market in Germany is influenced by a strong culture of self-care, wellness, and discreet enhancement. Many seek natural, balanced results, often for aging concerns rather than dramatic changes. High medical standards, privacy, and a stigma-free attitude toward aging gracefully motivate patients. Men are increasingly exploring facial and body procedures. In the UK, cosmetic surgery is fueled by social media, celebrity culture, and rising self-image concerns. Reality TV, influencers, and post-pandemic self-focus drive interest. Patients seek subtle improvements, often opting for non-surgical treatments first. Accessibility through private clinics and financing options makes aesthetic enhancements more attainable across age groups. Get the latest insights on healthcare industry segmentation with our Annual Membership: Segmental Insights By Procedures The surgical procedures segment held a dominant presence in the cosmetic surgery market in 2024, driven by a consistent preference for long-lasting results and advancements in minimally invasive techniques. Procedures such as breast augmentation, liposuction, rhinoplasty, and abdominoplasty are popular due to their ability to provide permanent aesthetic improvements that often surpass non-surgical options. Innovations like robotic-assisted surgeries have improved recovery times and reduced scarring, making these procedures more attractive. The presence of skilled surgeons and specialized clinics has further strengthened patient confidence, supporting the ongoing growth and market dominance of cosmetic surgery. The non-surgical procedures segment is anticipated to grow at the fastest rate in the market during the studied years due to their minimally invasive nature, lower costs, and shorter recovery times. Treatments such as Botox, dermal fillers, and laser therapies are increasingly favored for delivering subtle, natural results without surgery. The rising demand for aesthetic enhancements with minimal downtime and discomfort is propelling this trend, making non-surgical options more appealing and accessible to a wider audience. By Gender The female segment was dominant in the market in 2024, driven by cultural and societal pressures emphasizing beauty standards for women. The influence of social media, celebrity culture, and trends like the 'Instagram face' has encouraged more women to undergo procedures. Advances in technology have made treatments safer and more accessible, especially non-invasive options like Botox and fillers. Reduced stigma and easier financing have also contributed to this growth, with women increasingly seeking natural-looking enhancements aligned with confidence and modern beauty ideals. The male segment is predicted to grow at the highest CAGR in the market, as shifting perceptions of masculinity encourage men to pursue procedures such as liposuction, rhinoplasty, and Botox. The influence of social media and celebrities has helped normalize cosmetic enhancements among men. Additionally, rising obesity rates and greater access to minimally invasive technologies have boosted demand for body contouring and anti-aging treatments. These factors collectively drive rapid growth in the male cosmetic surgery market. By Age Group The 35 to 50 years segment held the highest share of the market in 2024, motivated by the desire to combat early signs of aging with treatments like Botox, fillers, and body contouring. This age group generally has greater financial stability, enabling investment in aesthetic improvements. Social and professional pressures to maintain a youthful appearance, coupled with technological advances, have made cosmetic procedures increasingly appealing and accessible. The 19 to 34 years segment is estimated to grow at the fastest CAGR during the predicted timeframe, driven by changing attitudes toward beauty and self-care. Younger consumers are more inclined toward non-invasive procedures like dermal fillers, laser treatments, and skin rejuvenation. The rise of influencer culture and online beauty trends has mainstreamed cosmetic enhancements. This demographic is also more willing to spend on personal appearance, prioritizing self-expression and confidence, which fuels market growth. By Provider The hospitals & specialty clinics segment held the largest share of the cosmetic surgery market in 2024, due to their advanced infrastructure, broad service range, and highly qualified staff. These facilities offer the latest technologies and adhere to strict safety standards, making them the preferred choice for both surgical and non-surgical procedures, which increases the demand. Their reputation for quality care and regulatory compliance has reinforced their leading position, which supports the growth and expansion of the market globally. The spas & cosmetic surgery centers segment is projected to grow at the fastest rate in the cosmetic surgery market during the forecast period. The growth of the market is driven by the rising focus on non-invasive and minimally invasive treatments like Botox, fillers, and laser therapies. These centers combine medical care with a relaxing atmosphere, attracting clients seeking quick results with minimal downtime. The popularity of aesthetic treatments, driven by social media, self-care trends, and wellness tourism, has significantly contributed to the rising demand in this segment, supporting the growth and expansion of the market. Become a valued research partner with us - Recent Developments in the Cosmetic Surgery Market In April 2025, Bliss Aesthetics announced a $17.5 million seed funding round. The company provides an AI-based digital platform that helps in connecting patients with board-certified plastic surgeons. In August 2024, AirSculpt Technologies, Inc. opened a new facility in Columbus, equipped with two operating rooms to allow multiple procedures at the same time. The center also expanded its treatment options by including the advanced AirSculpt skin tightening procedure, further enhancing its range of cosmetic services. Top Companies and Their Offerings to the Cosmetic Surgery Market Company Contributions & Offerings Evolus Inc. Specializes in aesthetic neurotoxins. Its flagship product, Jeuveau, is a Botox competitor focused purely on aesthetic use, marketed as a modern, millennial-friendly brand. Revance Offers Daxxify, a long-lasting botulinum toxin, and the RHA Collection of dermal fillers. Focuses on innovation, premium branding, and practitioner relationships. Galderma Known for Dysport (neurotoxin) and Restylane (filler line). It offers a wide portfolio in injectables, skincare (Cetaphil), and prescription dermatology, spanning all ages. AbbVie Owns Allergan Aesthetics, maker of Botox and Juvederm. It dominates the global injectable market and offers CoolSculpting and breast implants through Natrelle. Cynosure Develops energy-based devices for body contouring, hair removal, and skin revitalization, including SculpSure, PicoSure, and TempSure. Lumenis Offers advanced laser and IPL systems for skin resurfacing, hair removal, and gynecological aesthetics. Known for M22 and NuEra Tight platforms. Solta Medical Provides non-invasive aesthetic solutions such as Thermage (skin tightening), Fraxel (laser resurfacing), and Clear + Brilliant. Alma Lasers Offers devices for hair removal, tattoo removal, skin tightening, and body contouring. Known for Harmony XL Pro, Soprano, and Accent Prime. Syneron Candela Delivers aesthetic energy devices including CO₂RE, GentleMax Pro, and Vbeam. Strong in dermatology, vascular treatments, and pigment correction across global markets. Cosmetic Surgery Market Top Key Players Evolus Inc. Revance Galderma AbbVie Cynosure Lumenis Solta Medical Alma Laser Syneron Candela Browse More Insights of Towards Healthcare: The South Korea cosmetic surgery and procedures market is valued at USD 2.47 billion in 2024, increasing to USD 2.90 billion in 2025, and is expected to reach USD 12.14 billion by 2034, registering a robust CAGR of 17.23% from 2025 to 2034. The global skincare market is valued at USD 115.69 billion in 2024, growing to USD 123.64 billion in 2025, and projected to reach USD 224.83 billion by 2034, expanding at a CAGR of 6.87% during 2025–2034. The global skin repair market stands at USD 85.00 billion in 2024, rising to USD 90.58 billion in 2025, and is anticipated to reach USD 160.46 billion by 2034, growing at a CAGR of 6.56% between 2025 and 2034. The global personalized skin care products market is valued at USD 30.63 billion in 2024, expanding to USD 33.09 billion in 2025, and is expected to reach USD 66.37 billion by 2034, advancing at a CAGR of 8.04% from 2025 to 2034. The global skin repair dressing market was valued at USD 8.06 billion in 2023 and is projected to reach USD 16.45 billion by 2034, growing at a CAGR of 6.7% from 2024 to 2034. The global specialty medical chairs market is valued at USD 5.12 billion in 2025 and is expected to reach USD 9.77 billion by 2034, expanding at a CAGR of 7.43% during the forecast period. The global home healthcare market is projected to grow from USD 226.92 billion in 2025 to USD 476.80 billion by 2034, at a CAGR of 8.6% between 2025 and 2034. The global biopreservation market is valued at USD 3.65 billion in 2024, increasing to USD 4.68 billion in 2025, and is expected to surge to USD 44.51 billion by 2034, registering an impressive CAGR of 28.34% from 2025 to 2034. The global medical aesthetics market was valued at over USD 6.25 billion in 2024 and is anticipated to reach more than USD 8.64 billion by 2034, growing at a CAGR of 3.29% between 2025 and 2034. The global advanced liver cancer market is valued at USD 2.65 billion in 2024, growing to USD 2.97 billion in 2025, and is projected to reach USD 8.20 billion by 2034, expanding at a CAGR of 11.94% from 2025 to 2034. Segments Covered in The Report By Procedure Surgical Procedures Breast Augmentation Liposuction Eyelid Surgery Abdominoplasty Rhinoplasty Others Non-Surgical Procedures Botulinum Toxin Hyaluronic Acid Hair Removal Non-surgical Fat Reduction Photo Rejuvenation Others By Gender Female Male By Age Group 18 Years and Younger 19 to 34 Years 35 to 50 Years 51 to 64 Years 65 Years & Above By Provider Hospitals & Specialty Clinics Spas & Cosmetic Surgery Centers By Region North America U.S. Canada Asia Pacific China Japan India South Korea Thailand Europe Germany UK France Italy Spain Sweden Denmark Norway Latin America Brazil Mexico Argentina Middle East and Africa (MEA) South Africa UAE Saudi Arabia Kuwait Immediate Delivery Available | Buy This Premium Research @ Access our exclusive, data-rich dashboard dedicated to the healthcare market - built specifically for decision-makers, strategists, and industry leaders. The dashboard features comprehensive statistical data, segment-wise market breakdowns, regional performance shares, detailed company profiles, annual updates, and much more. From market sizing to competitive intelligence, this powerful tool is one-stop solution to your gateway Access the Dashboard: You can place an order or ask any questions, please feel free to contact us at sales@ Gain access to the latest insights and statistics in the healthcare industry by subscribing to our Annual Membership. Stay updated on healthcare industry segmentation with detailed reports, market trends, and expert analysis tailored to your needs. Stay ahead of the curve with valuable resources and strategic recommendations. Join today to unlock a wealth of knowledge and opportunities in the dynamic world of healthcare: Get a Subscription About Us Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics, with a strong emphasis on life science research. Dedicated to advancing innovation in the life sciences sector, we build strategic partnerships that generate actionable insights and transformative breakthroughs. As a global strategy consulting firm, we empower life science leaders to gain a competitive edge, drive research excellence, and accelerate sustainable growth. Our Trusted Data Partners Precedence Research | Statifacts | Towards Packaging | Towards Automotive | Towards Food and Beverages | Towards Chemical and Materials | Towards Consumer Goods | Towards Dental | Towards EV Solutions | Nova One Advisor | Healthcare Webwire | Packaging Webwire | Automotive Webwire Find us on social platforms: LinkedIn | Twitter | InstagramError in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store